GUELPH, ON / ACCESSWIRE / September 11, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce the successful results of a recent study conducted by ParticleOne, an RWDI Ventures company ("RWDI").
The study evaluated the performance of Zentek's ZenGUARD™-enhanced filter technology in comparison to a standard Minimum Efficiency Reporting Value ("MERV") 9 filter. The study was conducted to assess the effectiveness of filters in removing infectious particles from the air and to determine the potential return on investment ("ROI") of enhanced viral filtration from using ZenGUARD™ technology.
"Upon reviewing ZenGUARD™ HVAC filter performance, it is clear that the technology does not focus purely on physical removal of harmful pathogens but also on deactivating pathogens, thus preventing the particles from infecting occupants within the space," commented Justin Downey, RWDI Strategic Director and Principal. "Consequences of infectious disease will always exist and be significant, but with an enhanced understanding of risk mitigation tools like ZenGUARD™ HVAC filters and proactive planning, the expectation is that our future vulnerability to seasonal illness, surges in new variants of SARS-CoV-2, or even the spread of novel respiratory pathogens, can be lessened."
"Poor indoor air quality remains a significant challenge for employee health, wellness, and productivity. With this third-party assessment by ParticleOne, we have been able to help quantify the value proposition of ZenGUARD™ HVAC filters in helping address this problem," commented Greg Fenton, CEO of Zentek. "Importantly, ZenGUARD™ technology focuses on increasing viral filtration efficiency without additional equipment or an increase in energy consumption. We believe this combination is unique in the industry and incredibly important as we all look to improve people's health indoors while also reducing our carbon footprint."
ParticleOne Study Background:
Canadian Federal Government Opportunity
As previously disclosed, Zentek was awarded a Government of Canada testing contract and has successfully completed a nearly two-year testing program through Canada's Innovative Solutions Canada Testing Stream. Testing was in partnership with the NRC's Aerospace Research Centre, Construction Research Centre and Real Property Planning Management Groups. Part of the Innovative Solutions Canada Testing Stream is a Pathway to Commercialization program, which gives successful Canadian small and medium-sized enterprises the exclusive opportunity to sell their innovation directly to the Government of Canada through Public Services Procurement Canada.
Using a similar approach to the ParticleOne methodology above, the Company estimates that absenteeism costs across the entire Federal Public Service could be reduced by approximately $112.5 million. The key assumptions underlying the Company's analysis are as follows:
The above analysis is disclosed for illustrative purposes only, and there can be no assurance that (i) the assumptions used by the Company in conducting its analysis are accurate and correct, (ii) the above analysis is or will be accurate or consistent with any third-party analysis, (iii) any third-party, including but not limited to, and governmental branch or office, awards or offers any contract to the Company, or (iv) the Pathway to Commercialization program will result in any future sales or revenue for the Company, and readers should not place undue reliance on such analysis.
National Air Filtration Association (NAFA) Conference
Zentek will be participating in the 2023 NAFA Annual Convention from September 13-15 in Nashville, TN. This event brings hundreds of professionals from numerous companies in the air filtration industry under one roof. It's an important annual event for networking and for gaining insights into best practices and new technologies in the air filtration industry. The Company looks forward to discussing the results of its ZenGUARD™ ROI study and its recently disclosed viral filtration efficiency results with dust loading with NAFA attendees.
ParticleOne is virus-resiliency software for buildings, developed and used by the world-renowned environmental and building-performance engineers at RWDI.
Recognizing that healthy indoor air must include infectious disease controls, RWDI developed ParticleOne to evaluate the specific airborne viral risks in buildings and shared spaces. The software determines appropriate risk mitigation measures to better protect people and business operations.
About Zentek Ltd.
Zentek is an ISO 13485:2016 certified graphene technology company focused on the research, development and commercialization of graphene-based novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD™, is shown to have 99-per-cent antimicrobial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.
For further information:
Tel: (289) 821-2820
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at http://www.sedar.com/.
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Zentek Ltd.